The number of tumor cells positive for Ki-67, a cell proliferation marker, and p-S6RPs240/244, a protein indicating activity of the PI3K/mTOR pathway, was substantially lower in IB136 and resIB136 xenografts treated with BEZ235 compared with control tumors (Fig. 3c). This evidence concerns the gene MKI67 and neoplasm.